HALO
Halozyme Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$63.66
+0.10 ▲ +0.16%
🌙 3월 13일 7:31 PM ET (한국 3/14 08:31)
$64.24
+0.58 ▲ +0.90%
| Index | - | P/E | 25.55 | EPS (ttm) | 2.49 | Insider Own | 1.27% | Shs Outstand | 0.12B | Perf Week | -5.51% |
| Market Cap | 7.51B | Forward P/E | 6.46 | EPS next Y | 22.85% | Insider Trans | -15.68% | Shs Float | 0.12B | Perf Month | -19.93% |
| Enterprise Value | 9.55B | PEG | 0.17 | EPS next Q | 1.53 | Inst Own | 105.4% | Short Float | 11.58% | Perf Quarter | 1.61% |
| Income | 0.32B | P/S | 5.38 | EPS this Y | 93.16% | Inst Trans | 2.2% | Short Ratio | 7.16 | Perf Half Y | -17.89% |
| Sales | 1.40B | P/B | 153.6 | EPS next 5Y | 38.14% | ROA | 12.99% | Short Interest | 13.50M | Perf YTD | -5.41% |
| Book/sh | 0.41 | P/C | 52.6 | EPS past 3/5Y | 21.17% 22.89% | ROE | 153.59% | 52W High | -22.57% ($82.22) | Perf Year | 4.26% |
| Cash/sh | 1.21 | P/FCF | 11.66 | Sales past 3/5Y | 28.38% 39.16% | ROIC | 14.31% | 52W Low | 34.02% ($47.50) | Perf 3Y | 48.36% |
| Dividend Est. | - | EV/EBITDA | 10.56 | EPS Y/Y TTM | -25.45% | Gross Margin | 78.13% | Volatility(W/M) | 2.82% 3.38% | Perf 5Y | 43.48% |
| Dividend TTM | - | EV/Sales | 6.84 | Sales Y/Y TTM | 37.55% | Oper. Margin | 58.45% | ATR (14) | 2.27 | Perf 10Y | 604.98% |
| Dividend Ex-Date | - | Quick Ratio | 3.66 | EPS Q/Q | -213.27% | Profit Margin | 22.69% | RSI (14) | 28.93 | Recom | 2.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.66 | Sales Q/Q | 51.6% | SMA20 | -9.05% ($69.99) | Beta | 1.04 | Target Price | $84.5 |
| Payout | - | Debt/Eq | 44.61 | Earnings | 2000000 | SMA50 | -11.78% ($72.16) | Rel Volume | 0.6 | Prev Close | $63.56 |
| Employees | 423 | LT Debt/Eq | 44.37 | EPS/Sales Surpr. | -110.92% 3.69% | SMA200 | -4.5% ($66.66) | Avg Volume(3M) | 1.89M | Price | $63.66 |
| IPO | 2004/3/12 | Option/Short | Yes/Yes | Trades | 15190 | Volume | 1,134,140 | Change | 0.16% |
뉴스 로딩 중...